CC1(C)C(=O)C2C[C@]3(O)C4=CC(=O)OC(c5ccoc5)[C@]4(C)CCC3[C@](C)(C2=O)C1CC(=O)O
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?